Navigation Links
Genmab Reaches Milestone in Ofatumumab Collaboration
Date:10/10/2008

Summary: Genmab has Reached the Sixth Milestone in its Ofatumumab

Collaboration With GSK.

COPENHAGEN, Denmark, October 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK). A milestone payment of approximately DKK 29 million (approximately USD 5.6 million) was triggered by the first patient receiving treatment in the ofatumumab Phase I study in relapsed/refractory follicular non-Hodgkin's lymphoma and chronic lymphocytic leukemia in Japan.

Ofatumumab is an investigational, new generation, human monoclonal antibody that targets a distinct membrane proximal, small loop epitope ( specific binding site) of the CD20 molecule on the surface of B-cells. Ofatumumab is being developed to treat chronic lymphocytic leukemia, follicular non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis under a co- development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved for sale in any country.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
2. Genmab A/S - Changes Board/Management/Auditors
3. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
4. Genmab Announces 2008 First Quarter Results
5. Passing of Genmab A/S Annual General Meeting
6. Genmab A/S - Notice to Convene Annual General Meeting
7. Genmabs 2007 Annual Report
8. Genmab Announces Year End 2007 Financial Results
9. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
10. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
11. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...CISCO, Dec. 1 The Burrill Biotech ...value it lost in October. The Select,s gain of 4.5... for the general markets with the Dow up 6.5 perce...ns held firm in the final two trading days of the ...ksgiving holiday shopping and Dubai,s reported deb...
(Date:12/1/2009)..., N.J., Dec. 1 Palatin T...ed that the U.S. Patent and Trademark Office has i...triuretic Peptide Constructs." The claims in the ...hat bind to natriuretic peptide receptor A (NPRA),...rug candidate. ,, "Our natriuretic compounds, i...
(Date:12/1/2009)... HARBIN, China, Dec. 1 /PRNewswire-Asia-FirstCa... Medical" or "the Company") (Nasdaq: CSKI ), a le...loping and producing,over-the-counter drugs in the...ed that the Company has engaged Guangdong Mediacy ...K") to serve as its exclusive sales agent for the,...
(Date:12/1/2009)... DNA Genotek, a leading provider of products ...that Tepnel Pharmaceutical Services will offer Ora...s nucleic acid extraction and genotyping service. ...mber 1, 2009 -- DNA Genotek , a leading provider ...y announced that Tepnel Pharmaceutical Services ...
Breaking Biology Technology:Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3
... Setaram,Inc., a leading manufacturer of Thermal ... acquisition of Hy-Energy LLC (Newark, CA), a,manu...ic instruments for,the ever-expanding field of cle...adds a full suite of analytical capabilities which...Analysis and calorimetry,product lines," said Gill...
...s,Inc. (NYSE: BRL ) today announced that its subs... approval from the U.S. Food and Drug,Administrati...elheim,Pharmaceuticals, Inc.,s Mirapex(R) Tablets ...mg, 1mg & 1.5mg. The Company believes that it is t...on (ANDA) with a paragraph,IV certification for Mi...
...nology Providers Broadens Opportuniti...nd GAITHERSBURG, Md., Feb. 19 B-Line,Medical, LLC...Corporation,announced a strategic partnership enab...ersion of B-Line Medical,s SimCapture(TM) product....g, debriefing, assessing and,centralizing multiple...
Other Biology Technology:Setaram Inc. Acquires Hy-Energy LLC 2Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg 2Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg 3Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg 4B-Line Medical and Immersion Medical Announce Partnership 2B-Line Medical and Immersion Medical Announce Partnership 3
(Date:12/1/2009)...sity cancer researchers have developed a tumor-at...d blocks the growth of new tumor blood vessels. ,...ll cancer cells oncolytic viruses might be more ...also carry a gene for a protein that inhibits bloo...tin, is normally produced in the brain. In this st...
(Date:12/1/2009)...the United States, the other from Canada, put the ... pack, on remote Ellesmere Island, only 600 miles ...ut what these "North Pole wolves" do in the long, ...f the world., "We first encountered 9-year-old B....S. Geological Survey (USGS) wolf researcher who h...
(Date:12/1/2009)...sity-led international research team has developed... generation of solar cells. , Scientists at Mona...om the universities of Wollongong and Ulm in Germa...s with a three-fold increase in energy conversion ...m dye-sensitised solar cells. , Lead researcher...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Innovation puts next-generation solar cells on the horizon 2Louisiana Tech University receives grant to advance women in engineering science 10140 1Louisiana Tech University receives grant to advance women in engineering science 10140 2Director of UT Southwestern center honored with first international neurology medal 58412 1Director of UT Southwestern center honored with first international neurology medal 58412 2Chinas new Climate Center welcomes citizen scientists 10136 1Chinas new Climate Center welcomes citizen scientists 10136 2
...eading at an alarming rate throughout Britain,s co...se mitten crab, brought to Britain during the last...stating environmental problems if populations are ...ors. , Researchers from the University of Newcas...modelling of the crab,s migration through Europe a...
...ioinformatics Institute (VBI) and the Department o...ife Sciences at Virginia Tech have developed a new...DNA sequences into the genome of strawberry. The s...ure,s genetic engineer, to introduce DNA into the ...he method takes advantage of Agrobacterium,s circu...
...atter how hard we try. Whether it,s deleting a com... we can,t get it back, or dropping a bag of grocer...y on a lonely stretch of highway, we all make mist...stly. , Now, a team of University of Michigan rese...ured the instant when someone makes a costly mista...
Other Biology News:Exotic crab poised for widespread UK invasion 2Exotic crab poised for widespread UK invasion 3Strawberries by design 2Oops! Researchers publish new findings on the brain's response to costly mistakes 2Oops! Researchers publish new findings on the brain's response to costly mistakes 3Oops! Researchers publish new findings on the brain's response to costly mistakes 4
...ically to Fc regions of many mammalian immunoglobu...nly used as affinity adsorbents to purify immunogl...rom serum, hybridoma ascites fluids, tissue cultur...reagents are also commonly used to capture immune ...
...ically to Fc regions of many mammalian immunoglobu...nly used as affinity adsorbents to purify immunogl...rom serum, hybridoma ascites fluids, tissue cultur...reagents are also commonly used to capture immune ...
CORNING PETRI DISH, 100 X 20 MM, PS, ULTRA LOW BINDING, STERILE from Sigma-Aldrich
...locks, 96-well PCR plate, 0.3ml maximum well volum...ay corner , Fits all 0.2ml thermal cyclers and ABI...ear well bottom for sample visibility, Highly rigi... Films and Foils, Heat Seals and Flat and Domed Ca...
Biology Products: